- Home
- CCBG vs CRMD Comparison
CCBG vs CRMD Comparison
Compare CCBG & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- CRMD
- Stock Information
- Founded
- CCBG 1895
- CRMD 2006
- Country
- CCBG United States
- CRMD United States
- Employees
- CCBG N/A
- CRMD N/A
- Industry
- CCBG Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- CRMD Health Care
- Exchange
- CCBG Nasdaq
- CRMD Nasdaq
- Market Cap
- CCBG 671.1M
- CRMD 877.5M
- IPO Year
- CCBG N/A
- CRMD 2010
- Fundamental
- Price
- CCBG $40.77
- CRMD $11.30
- Analyst Decision
- CCBG Buy
- CRMD Strong Buy
- Analyst Count
- CCBG 2
- CRMD 7
- Target Price
- CCBG $39.00
- CRMD $17.33
- AVG Volume (30 Days)
- CCBG 41.3K
- CRMD 2.3M
- Earning Date
- CCBG 07-22-2025
- CRMD 08-13-2025
- Dividend Yield
- CCBG 2.36%
- CRMD N/A
- EPS Growth
- CCBG 11.98
- CRMD N/A
- EPS
- CCBG 3.37
- CRMD 0.28
- Revenue
- CCBG $236,037,000.00
- CRMD $82,553,827.00
- Revenue This Year
- CCBG $10.45
- CRMD $278.96
- Revenue Next Year
- CCBG $3.50
- CRMD $45.85
- P/E Ratio
- CCBG $12.06
- CRMD $40.83
- Revenue Growth
- CCBG 6.63
- CRMD N/A
- 52 Week Low
- CCBG $29.83
- CRMD $3.61
- 52 Week High
- CCBG $42.00
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CCBG 63.75
- CRMD 40.02
- Support Level
- CCBG $40.25
- CRMD $11.13
- Resistance Level
- CCBG $41.59
- CRMD $11.86
- Average True Range (ATR)
- CCBG 0.94
- CRMD 0.48
- MACD
- CCBG 0.13
- CRMD -0.25
- Stochastic Oscillator
- CCBG 84.02
- CRMD 5.09
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.